Article Sidebar
Views PDF: 309
Evaluation the effectiveness of the extrahepatic arterial chemoembolization on treatment of hepatocellular carcinoma in Radiology center of Bach Mai Hospital
Main Article Content
Abstract
Purpose: Evaluation the effectiveness of the extrahepatic arterial chemoembolization on treatment of hepatocellular carcinoma.
Subjects and methods: There is a non-controlled prospective intervention study in HCC patients with tumors which had blood supply from extrahepatic arteries from July 2019 to August 2020 in Radiology center of Bach Hospital.
Results:. Our study was performed on 56 patients including 48 men (85.7%) and 8 women (14.3%) who were diagnosed with HCC. The mean age were 58.29 ± 10,849 years old. The rate of successful approaching to the extrahepatic vessel branches was 83.05%. There were 2 patients (3.58%) had acute complications during and immediately after intervention. Special complications related directly to the extra-hepatic embolization were observed in 14 patients (25%). After an average of
2.25 ± 0.919 months of follow-up, 1 patient (1.8%) re-examined due to rupture of liver tumor, the remaining 55 patients (98.2%) were reexamined by appointment. The results of tumor response according to mRECIST with complete response, partial response, stable disease and progressive disease were 3.6%, 52.7%, 25.5%, and 18.2% respectively.
Conclusion: The results of the extrahepatic arterial chemoembolization in our study had high rates of the successful
approaching to the extrahepatic vessel branches, the intervention safety and the post-intervention tumor response.
Article Details
Keywords
TACE, Extrahepatic artery supply to HCC
References
2. Hs L., Js K., Ij C. và cộng sự. (1997). The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer, , accessed: 06/09/2020.
3. Carr B.I. (2004). Hepatocellular carcinoma: Current management and future trends. Gastroenterology, 127(5), S218–S224.
4. Lo C.-M., Ngan H., Tso W.-K. và cộng sự. (2002). Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatol Baltim Md, 35(5), 1164–1171.
5. Llovet J.M. và Bruix J. (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatol Baltim Md, 37(2), 429–442.
6. Chung J.W., Park J.H., Han J.K. và cộng sự. (1998). Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol JVIR, 9(3), 495–500.
7. Hc K., Jw C., W L. và cộng sự. (2005). Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics : a review publication of the Radiological Society of North America, Inc, https://pubmed.ncbi.nlm.nih.gov/16227494/>, accessed: 12/08/2020.
8. Ferlay J., Colombet M., Soerjomataram I. và cộng sự. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer, 144(8), 1941–1953.
9. Mittal S. và El-Serag H.B. (2013). Epidemiology of HCC: Consider the Population. J Clin Gastroenterol, 47(0), S2–S6.
10. Chen C.-J., Yang H.-I., Su J. và cộng sự. (2006). Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA, 295(1), 65–73.
11. Young M. và John S. (2020). Hepatic Chemoembolization. StatPearls. StatPearls Publishing, Treasure Island (FL).
12. Yu S.J. (2016). A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016. Clin Mol Hepatol, 22(1), 7–17.
13. Kim H.-C., Chung J.W., Lee W. và cộng sự. (2005). Recognizing Extrahepatic Collateral Vessels That Supply Hepatocellular Carcinoma to Avoid Complications of Transcatheter Arterial Chemoembolization. RadioGraphics, 25(suppl_1), S25–S39.
14. Chen G., Song B., Li Z. và cộng sự. (2013). Ectopic Blood Supply of Hepatocellular Carcinoma as Depicted by Angiography with Computed Tomography: Associations with Morphological Features and Therapeutic History. PLOS ONE, 8(8), e71942.
15. As M., Ak A.A., N E. và cộng sự. (2017). Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical Considerations. Radiographics : a review publication of the Radiological Society of North America, Inc, https://pubmed.ncbi.nlm.nih.gov/28362557/>, accessed: 12/08/2020.
16. Sw S., Ys D., Sw C. và cộng sự. (2006). Diaphragmatic weakness after transcatheter arterial chemoembolization
of inferior phrenic artery for treatment of hepatocellular carcinoma. Radiology, , accessed: 07/09/2020.
17. Tajima T., Honda H., Kuroiwa T. và cộng sự. (2002). Pulmonary Complications after Hepatic Artery Chemoembolization or Infusion via the Inferior Phrenic Artery for Primary Liver Cancer. J Vasc Interv Radiol, 13(9), 893–900.
18. Chu H.H., Kim H.-C., Chung J.W. và cộng sự. (2014). Repeated Intra-Arterial Therapy via the Cystic Artery for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol, 37(5), 1283–1291.
19. Shah R.P. và Brown K.T. (2011). Hepatic Arterial Embolization Complicated by Acute Cholecystitis. Semin Interv Radiol, 28(2), 252–257.
20. McWilliams J.P., Kee S.T., Loh C.T. và cộng sự. (2011). Prophylactic Embolization of the Cystic Artery Before Radioembolization: Feasibility, Safety, and Outcomes. Cardiovasc Intervent Radiol, 34(4), 786–792.